| Medical and Health Sciences | Lifetime | 797 | GB 88 | 99.96 |
| Hematology | Lifetime | 35 | GB 1 | 99.80 |
| Medical Genetics | Lifetime | 111 | GB 6 | 99.18 |
| Public, Environmental and Occupational Health | Lifetime | 610 | GB 71 | 99.15 |
| Oncology | Lifetime | 790 | GB 59 | 98.32 |
| Pathology and Forensic Medicine | Lifetime | 663 | GB 61 | 97.01 |
| Immunology | Lifetime | 936 | GB 64 | 96.78 |
| Transplantation | Lifetime | 491 | GB 27 | 77.53 |
| Hematology | 2021-2025 | 60 | GB 4 | 98.70 |
| Public, Environmental and Occupational Health | 2021-2025 | 361 | GB 33 | 96.86 |
| Medical Genetics | 2021-2025 | 116 | GB 4 | 95.50 |
| Oncology | 2021-2025 | 593 | GB 26 | 91.29 |
| Pathology and Forensic Medicine | 2021-2025 | 293 | GB 20 | 90.78 |
| Immunology | 2021-2025 | 514 | GB 21 | 85.34 |
| Political and Social Philosophy | 2021-2025 | 76 | GB 5 | 43.39 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 955 | GB 63 | 74.16 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 26 | GB 1 | 99.84 |
| Acute Myeloid Leukemia Research | Lifetime | 47 | GB 2 | 99.77 |
| Neutropenia and Cancer Infections | Lifetime | 17 | GB 1 | 99.66 |
| Acute Lymphoblastic Leukemia research | Lifetime | 47 | GB 1 | 99.71 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 41 | GB 3 | 99.70 |
| Hematological disorders and diagnostics | Lifetime | 22 | GB 3 | 99.42 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 120 | GB 9 | 99.61 |
| Lymphoma Diagnosis and Treatment | Lifetime | 200 | GB 16 | 99.37 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 91 | GB 7 | 99.16 |
| Mesenchymal stem cell research | Lifetime | 197 | GB 11 | 98.82 |
| Eosinophilic Disorders and Syndromes | Lifetime | 172 | GB 16 | 98.51 |
| Multiple Myeloma Research and Treatments | Lifetime | 304 | GB 18 | 98.21 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 612 | GB 50 | 97.52 |
| Polyomavirus and related diseases | Lifetime | 336 | GB 15 | 97.21 |
| Effects of Radiation Exposure | Lifetime | 340 | GB 47 | 96.40 |
| Viral-associated cancers and disorders | Lifetime | 674 | GB 47 | 96.72 |
| Transplantation: Methods and Outcomes | Lifetime | 916 | GB 42 | 96.07 |
| Kruppel-like factors research | Lifetime | 415 | GB 23 | 92.80 |
| Nuclear Issues and Defense | Lifetime | 300 | GB 33 | 89.20 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 56 | GB 1 | 98.80 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 45 | GB 1 | 98.89 |
| Acute Myeloid Leukemia Research | 2021-2025 | 121 | GB 5 | 98.77 |
| Immune Cell Function and Interaction | 2021-2025 | 278 | GB 9 | 96.21 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 223 | GB 13 | 97.39 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 122 | GB 6 | 97.70 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 135 | GB 5 | 96.59 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 157 | GB 9 | 93.30 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 854 | GB 44 | 92.99 |
| Effects of Radiation Exposure | 2021-2025 | 220 | GB 7 | 84.57 |
| Neutropenia and Cancer Infections | 2021-2025 | 455 | GB 7 | 78.34 |
| Kruppel-like factors research | 2021-2025 | 375 | GB 12 | 67.28 |
